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Background: Neck pain is one of the chief symptoms of cervical spondylosis (CS). Acupuncture is a well-accepted
and widely used complementary therapy for the management of neck pain caused by CS. In this paper, we present
a randomized controlled trial protocol evaluating the use of acupuncture for CS neck pain, comparing the effects of
the optimized acupuncture therapy in real practice compared with sham and shallow acupuncture.
Methods/Design: This trial uses a multicentre, parallel-group, randomized, sham acupuncture and shallow
acupuncture, controlled single-blind design. Nine hospitals are involved as trial centres. 945 patients who meet
inclusion criteria are randomly assigned to receive optimized acupuncture therapy, sham acupuncture or shallow
acupuncture by a computerized central randomization system. The interventions past for 4 weeks with eight to ten
treatments in total. The group allocations and interventions are concealed to patients and statisticians. The
Northwick Park Neck Pain Questionnaire (NPQ) is used as the primary outcome measure, and the McGill Pain
Questionnaire (MPQ) and The Short Form (36) Health Survey (SF-36) are applied as secondary outcome measures.
The evaluation is performed at baseline, at the end of the intervention, and at the end of the first month and the
third month during follow-up. The statistical analyses will include baseline data comparison and repeated measures
of analysis of variance (ANOVA) for primary and secondary outcomes of group and time differences. Adverse events
(AEs) will be reported if they occur.
Discussion: This trial is a multicentre randomized control trial (RCT) on the efficacy of acupuncture for CS neck pain
and has a large sample size and central randomization in China. It will strictly follow the CONSORT statement and
STRICTA extension guideline to report high-quality study results. By setting the control groups as sham and shallow
acupuncture, this study attempts to reveal the effects of real acupuncture versus placebo or non-classic
acupuncture treatment and evaluate whether classic Chinese medical acupuncture is effective on CS neck pain. This
study will provide evidence for the effects of acupuncture on CS neck pain.
Trial Registration: Chinese Clinical Trial Registry: ChiCTR-TRC-00000184.
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Cervical spondylosis (CS) is caused by unspecified de-
generative changes of the muscles, tendons, joints, and
bones of the neck and shoulder [1]. The main symptom
of CS is pain and stiffness in the neck, sometimes ac-
companied by numbness and radicular pain to the arms
and fingers. The overall prevalence of neck pain has
been reported [2] as ranging from 0.4% to 86.8% (mean
23.1%). In a high-risk population (office and computer
workers), the 1-year incidence of neck pain ranged from
10.4% to 21.3% [2], and most of these cases are empiric-
ally determined to be caused by CS (hereafter referred to
as CS neck pain).
The management goals for CS neck pain are to diminish
pain intensity, facilitate physical neck movement, and re-
store daily function. Therapies for the disorder include both
individual (administration of non-steroidal anti-
inflammatory drugs), muscle relaxants, and analgesics [3]),
and public (establishment of healthcare policies and the de-
livery of healthcare advice, physical training and stress man-
agement techniques [4]) treatment approaches. However,
little evidence is available to support the effectiveness of
care at either the public or individual healthcare level [3,4].
Complementary therapies such as acupuncture, mas-
sage, neck exercises, mechanical traction, and electrother-
apy are well accepted as alternative treatments for CS
neck pain. Acupuncture has been extensively used for the
management of CS neck pain, and a number of clinical
trials have been conducted to test its efficacy. However,
the evidence remains moderate, because of defects in
study design and in evaluation methods used in current
systematic reviews [5].
One problem is that many new acupuncture methods
have been introduced in these studies. For example,
trigger-point acupuncture was reported to be effective
for chronic neck pain in elderly patients [6]. Another
study reported that tender-point acupuncture had short-
term effects on neck and shoulder pain and stiffness [7].
Traditional acupuncture therapy is based on the classical
knowledge of Chinese medicine, and acupuncture point
selection should follow those classical principles and
specific locations. Thus, the aforementioned studies pro-
vide evidence only for the efficacy of needle insertion,
not for the efficacy of acupuncture per se.
Problems in the design of some studies have also been
identified. Some trials had a small sample size without
the correct calculation of the sample size required to
give meaningful statisics [6-8], whereas others lacked a
meaningful control group [9] or blinding techniques to
prevent subjective bias [10,11]. Therefore, a well-
designed, multicentre RCT with sound methods for cal-
culating sample size and establishing a meaningful
control group is needed to evaluate the effects of classic
Chinese acupuncture for the treatment of CS neck pain.The current study was designed as a randomized, con-
trolled, single-blind study, covering nine centres and
comparing three groups (one treatment group and two
control groups).. The sample size was calculated based
on the data from a 178-case pilot study [1] and referred
to the large-scale pragmatic trial design recommenda-
tion proposed by Salter et al. [12]. The objective of the
trial was to evaluate the effects of optimized acupunc-
ture therapy (OAT) for CS neck pain.
The trial protocol is reported here in accordance with
CONSORT 2010 statement [13], and the intervention
acupuncture details are described in accordance with the
STRICTA 2010 extension [14,15].
Methods/Design
Ethics review and informed consent
The study protocol was reviewed and approved by the
Ethics Committee of Guangdong Provincial Hospital of
Chinese Medicine (number 2008GL-10),and registered
in the Chinese Clinical Trial Registry (number ChiCTR-
TRC-00000184), which is a primary registry in the
WHO registry network (http://www.chictr.org/). All
patients are required to provide informed consent.
Trial status
Patients are currently being recruited into the study, and
the follow-up is being conducted.
Trial design
The study was designed as a randomized, parallel-group,
single-blind trial to evaluate the effects of OAT for CS
neck pain. The following nine hospitals located in differ-
ent regions of China were chosen for involvement in the
trial: Guangdong Provincial Hospital of Chinese Medi-
cine, the First Affiliated Hospital of Hunan University of
Chinese Medicine, the Secondary Affiliated Hospital of
Hunan University of Chinese Medicine, Xinjiang Med-
ical University Affiliated Hospital of Traditional Chinese
Medicine, the Third Hospital of Shanxi Institute of
Traditional Chinese Medicine, the Second Affiliated
Hospital of Guiyang Institute of Traditional Chinese
Medicine, the People’s Hospital of Hainan Province, the
Second People’s Hospital of Zhaoqing City, and the Peo-
ple’s Hospital of Huizhou City.
Study procedure and patient recruitment
The study procedure is illustrated in the flow chart in
Figure 1.
The researchers will distribute trial information leaflets
to the outpatient clinics of the hospitals, local communi-
ties, and university campuses to recruit potential patients
whose major symptoms are neck pain and stiffness. The
leaflets contain a brief questionnaire for screening patients
with CS and provide contact information for the
Figure 1 Patient recruitment.
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and radiography assessment to confirm the diagnosis of
CS, and the protocol details are explained to them.
Patients are included only if they meet the inclusion cri-
teria and sign an informed consent document.
Inclusion and exclusion criteria
The inclusion criteria for the trial are:
 Age 18 to 60 years (both males and female patients
are included).
 A confirmed diagnosis of CS in accordance with the
diagnostic criteria published by Chinese Medical
Association and referring to the InternationalClassification of Diseases, 10th edition (ICD-10)[16]
codes: M47.2 (other spondylosis with radiculopathy),
M47.8 (other spondylosis! cervical spondylosis), or
M47.0 +G99.2* (anterior spinal and vertebral artery
compression syndromes).
 Diagnosis of CS supported by a cervical radiographic
examination, such as anteroposterior and lateral
X-rays, or magnetic resonance imaging/computed
tomography scans showing cervical spine
degeneration or cervical disc herniation.
 The main symptom of neck pain.
 Episodes of neck pain episodes lasting at least 0.5
hours, and occurring at a frequency of at least once
per month for the 3 months prior to study entry.
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a visual analog scale (VAS) at the time of
recruitment.
 No acupuncture therapy within the 3 months prior
to study entry.
The exclusion criteria are:
 Pregnancy or lactation.
 Confirmed diagnosis of spondylogenic compression
of the spinal cord referring to the ICD-10 [16] code
M47.1 +G99.2*.
 Complications of severe systematic diseases such as
diabetes mellitus, cardiocerebrovascular disorders or
tumors
 Considered not suitable to participate the trial by
the researchers.
 History of neck trauma, cervical fracture or cervical
surgery, neurologic impairment (for example,
myasthenia or abnormal spinal nerve reflex), or
congenital spinal abnormality, or a diagnosis of
systemic disease of the bones or joints.
 Duration of neck pain and/or neck stiffness episodes
of less than 0.5 hours or history of episodes have
occurred over less than< 3 months.
 Rejection or fear of acupuncture therapy.
 Use of any type of acupuncture within the 3 months
prior to study entry.
 Use of any other treatments (drug or non-drug).
Data collection
The demographic, baseline characteristics, and clinical
outcome data will be collected in the clinics where the
patients are treated. The questionnaires to assess treat-
ment effects and physical conditions are to be completed
by the patients after the treatment is completed. During
the follow-up period, the participants are requested to
return to the clinics to provide follow-up information
and will be given subsidies to cover transportation and
lost income based on the local minimum wage.
Treatment regimen
Patients are required to receive eight to ten treatment
sessions, at a frequency of two to three times a week.
The intervention should be completed in 4 weeks.
Interventions
The treatment scheme originates from the classical prin-
ciples of traditional Chinese medicine and has been
practiced in Guangdong Provincial Hospital of Chinese
Medicine for some time. The final scheme was discussed
and revised with the advice from a national expert com-
mittee of acupuncturists organized by the State Admin-
istration of Traditional Chinese Medicine (SATCM) ofChina. We hypothesized that OAT would have a specific
effect on CS neck pain and be superior to both placebo
and non-specific effects, therefore, two control groups
were designed, in addition to the treatment group, as
detailed below.
The optimized acupuncture therapy group
The treatment scheme for the OAT group consists of
traditional acupuncture therapy, followed by intradermal
needle therapy (INT). Nine acupuncture points were
selected for the OAT group based on the advice and
consensus of the national expert committee of acupunc-
turists detailed above. The name/code and location of
the acupuncture points followed the WHO standards
where possible [17-19], and are: Jianzhongshu (SI15, bi-
lateral); Dazhui (GV14); Zhongzhu (TE3, bilateral); and
Huatuojiaji (extra point; four points in two pairs, bilat-
eral). The Huatuojiaji points are traditional Chinese acu-
puncture points, but are not listed in the WHO
standard. To locate these four points, the acupuncturist
needs to identify the cervical positive reaction planes by
palpating the area 12.5 mm away from the patient’s cer-
vical vertebra. If any tender points are found, the corre-
sponding cervical vertebra level is considered the
cervical positive reaction plane. The four Huatuojiaji
points are located at the top ( upper Huatuojiaji) and
bottom (lower Huatuojiaji) of th cervical positive reac-
tion plane(s) bilaterally and 12.5 mm horizontally away
from the corresponding cervical vertebra. If only one
cervical positive reaction plane is identified, the practi-
tioner should select a pair of the Huatuojiaji points on
the cervical positive reaction plane and a second pair on
the cervical vertebra next to the first pair.
The doctors performing all therapies have at least 5
years of acupuncture experience. Disposable stainless
steel needles (0.3 mm×40 mm; Suzhou Tianxie Acu-
puncture Instruments Co. Ltd, Su Zhou City, China) are
used. The needles are inserted into the muscular tissue
of the acupuncture points (to a depth of 20 mm) using
the tube-guide method. The inserted needles are manu-
ally manipulated until the patient feels numbness or
other acupuncture sensation (known as ‘de qi’), and the
needles will be retained in the points for 20 minutes.
Following this tradition acupuncture therapyt, patients
are treated by INT. There are two point selection schemes
used alternatively: 1) the upper Huatuojiaji (bilateral) and
Dazhui (GV14) and 2) the lower Huatuojiaji (bilateral)
and Jianzhongshu (SI15; bilateral). Disposable stainless
steel intradermal needles (0.22 mm×5 mm; Suzhou Tian-
xie Acupuncture Instruments Co. Ltd.) are inserted into
the skin to the subcutaneous tissue at an angle of 15
degrees to the point surface. The direction of needle inser-
tion in Dazhui (GV14) is parallel to the spine, and in Hua-
tuojiaji and Jianzhongshu (SI15), it is vertical to the spine.
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their hilts remaining outside the skin, and will not be
removed until the next treatment session.
The sham acupuncture group
Skin-penetrating shallow needles on sham points are
used in the sham group. The location of the sham points
is defined as 25 mm lateral to the standard location used
in the OAT group: the sham point of Dazhui (GV14) is
25 mm vertically below the standard GV 14, the sham
points of Jianzhongshu (SI15) and Huatuojiaji are 25
mm lateral to the standard SI15 and the corresponding
points of Huatuojiaji, and the sham point of Zhongzhu
(TE3) is 25 mm proximal to the standard Zhongzhu
(TE3). The same type of disposable stainless-steel nee-
dles is used in the sham group as in the OAT group,
therefore, the intervention in the sham group cannot be
differentiated by needle appearance. The needles (0.22
mm×40 mm) are inserted into the skin to a depth of 3
mm and remain at the subcutaneous level for 20 min-
utes. The doctor uses the tube-guide method, and any
manipulation for acupuncture sensation or de qi is
prohibited.
After sham acupuncture, the patients will be treated
by point pressing. The point selection scheme is the
same as for the INT in the OAT group. To ensure blind-
ing, Semen Vaccariae (the seeds of the cow cockle, Vac-
caria hispanica) are used to press on each point to
conceal from the patient whether INT is being adminis-
tered; as the points are all on the back, the patient can-
not see what is being pressed on their skin.
The shallow acupuncture group
For the shallow group, the point selectionp is the same
as for the OAT group; however, the doctor is required to
insert the needles vertically to the subcutaneous level at
a depth of no more than 3 mm. Any sensation (de qi) or
needle manipulation is prohibited in this group. After
acupuncture, the patients will also treated by INT using
the same method as in the OAT group.
Randomization
Randomization is performed using a central randomization
interactive voice operating system (CRIVOS) developed
by the Design, Measurement and Evaluation in Clinical
Research (DME) centre of Guangzhou University of
Chinese Medicine. The random allocation sequence
was generated by an independent statistician from the
DME centre using SAS software (SAS Institute, Cary,
NC, USA), which was uploaded to CRIVOS. The doctors
and researchers from all centers can connect to the
CRIVOS system by telephone at any time to acquire the
allocation result when they are enrolling participants.
To enroll a patient, the doctor first confirms the patientqualifies for inclusion, then the doctor telephones the
CRIVOS system and follows the voice instruction given,
and finally, the doctor records the allocation informa-
tion. There are three numbers indicating the allocation
result: 001 represents the OAT group, 002 represents
the shallow group, and 003 represents the sham group.
Blinding
Because the efficacy of acupuncture inevitably depends
on the skill of the operating doctors, allocation conceal-
ment to the doctors is not feasible for trials on acupunc-
ture. Consequently, we applied a single-blind design in
which the patients are blinded to their allocation. The
statisticians are blinded to all treatment allocations
throughout the study.. The concealment will not be
broken until the final data analysis report is completed.
During and intervention phrase, the participants are
treated with tube-guided needles that have the same ap-
pearance as the treatment needles. Similarly, use of the
seeds in the sham acupuncture group gives the patient
the sensation of a needle being inserted. Both the genu-
ine acupuncture points and the sham points are in simi-
lar locations on the patients’ neck, back, and hands, and
the participants cannot observe the manipulation per-
formed during the treatment, therefore, the blinding
should be effective.The requirements for the treatment
sessions (the duration and frequency) are the same.
After the second session and at the end of the treatment,
participants are required to complete a questionnaire to
assess the blinding.
Outcomes
Three well-recognized patient-reported outcome (PRO)
tools are used to measure the effect outcomes. The North-
wick Park Neck Pain Questionnaire (NPQ) is used as the
primary outcome measure, and the McGill Pain Question-
naire (MPQ) and the Medical Outcomes Study Short Form
36 (SF-36) are used as secondary outcome measures.
Primary outcome
The NPQ [20] is composed of nine items that measure:
1) neck-pain intensity, 2) relationship between neck pain
and sleeping, 3) sensation of pins and needles in the
arms at night, 4) duration of symptoms, 5) ability to
carry items, 6) read and watch TV, 7) ability to work/
perform housework, 8) ability to perform social activities
(for example, doing leisure activities, visit friend.); and 9)
ability to drive. The NPQ produces an overall percentage
score, with a higher score reflecting a more serious dis-
ease state.
Secondary outcomes
The MPQ is a classic tool proposed by Melzack [21] for
assessing the intensity of non-specific pain, and a higher
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general tool to measure medical outcomes and quality of
life (QOL) [22,23]. The SF-36 consists of assessing out-
comes in eight domains to represent patient QOL in
physical, mental and social dimensions. A higher score
reflects a better QOL in the corresponding domain.
In this trial, analgesic use is not recommended. How-
ver, based on bioethical considerations, the researchers
will be able to provide free ibuprofen sustained-release
capsules (Fenbid; GSK-China, Shanghai, China); State
Food and Drugs Administration (China) registration
number H10900089.) to the included subjects who re-
quest analgesic. The dose is 0.3 g (one capsule) orally,
twice daily (morning and evening). The subjects’ anal-
gesic use will be recorded and any use of analgesic be-
yond this will be considered a protocol violation.
Outcome measuring procedure and data collection
The outcomes will be assessed before the first treatment
(baseline measurement), immediately after the final
treatment (short-term outcome of therapeutic effect),
and at the end of the first and third months after the
final treatment (long-term effective outcomes). The data
will be by PRO, with the questionnaires being completed
by the participants themselves with necessary instruction
from the researchers. Medication use at baseline, during
the intervention, and at the 3-month follow-up will be
recorded.
Safety evaluation
Any expected and unexpected adverse events (AEs) will
be recorded during the treatment. The expected AEs in-
clude local bleeding at the needle insertion points, and
local numbness, pain, and dizziness during treatment. If
any AE occurs, the doctor will provide corresponding
treatment to the patient in accordance with the study
protocol. The researcher will complete the adverse
events/reaction form in the case report form and report
the AE to the primary investigator and ethics committee
immediately, who will make a decision on whether the
patient needs to withdraw from the trial.
Sample size calculation
The size calculation is based on the mean and standard
deviation (SD) for NPQ from a pilot study [1]. The
reported pilot study was a two-arm design with a treat-
ment group and one placebo group, whereas this trial
protocol is a three-arm design with one treatment group
(OAT) and two control groups (sham group and shallow
group). The mean ± SD of the treatment group reported
in the pilot study (20.71 ± S 11.91) [1] were used as the
expected values of the OAT group, and the mean ± SD
of the placebo group (24.04 ± 11.83) were used as the
expected values of the two control groups. The softwarePower Analysis and Sample Size (PASS; version 11;
NCSS Statistical Software, Kaysville, UT, USA) was used
to perform the sample size calculation.
The sample size was calculated with a significance
level of 0.05 and power of 0.90. The result was a total
required sample size of 732, with 244 for each group.
With a maximum dropout tolerance of 15%, 32 patients
per center are needed for each group, or 94 patietns
overall per center. Therefore, 846 patients are needed
for the trial, with 288 for each group across the nine
centers.
Statistical analyses
EpiData software (version 3.1 is used for data entry, and
SPSS (version 16.0; SPSS Inc., Chicago, IL, USA) for
statistical analyses. The analytic strategy includes the de-
scriptive analysis of the demographic characteristics and
the baseline data for the primary and secondary out-
comes. The group differences are tested by analysis of
variance (ANOVA) for continuous variables, the
Kruskal-Wallis test for ranking variables, and the χ² test
for categorical variables. The significance level is set at
α= 0.05, two-sided.
There are four measuring points set to assess the effi-
cacy of the OAT, as described above in the Outcomes
section. Therefore, we will apply the two-factor repeated
measures analysis of variance (ANOVA) model with the
time of measure as the within-subjects factor and treat-
ment as the between-subjects factor (significance level
α= 0.05, two-sided). In addition, stratification analysis
will be used to explore the potential effect difference be-
tween centres.
Discussion
The objective of this trial is to evaluate the effect of the
OAT scheme for neck pain in patients with CS. The first
draft of the OAT treatment scheme was developed based
on the practice and clinical experience of the Acupunc-
ture Department of Guangdong Provincial Hospital of
Chinese Medicine. The draft was then discussed by a
special committee of Guangdong Association of Acu-
puncture and revised. The revised edition was submitted
and reviewed by the national expert committee of acu-
puncturists organized by SATCM, and the final version
of the OAT scheme was approved by the consensus of
the committee.
The OAT scheme comprises two steps: the first step is
classic acupuncture therapy at the nine standard points
with de qi sensation for 20 minutes, and the the second
step is the administration of INT in which the needles
are fixed by medical tape. The treatment lasts for 4
weeks with eight to ten sessions at a frequency of two to
three times per week. The overall effect of OAT is
related to the duration and frequency of the treatment.
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maintain the pain-relieving effect of classic acupuncture,
therefore, the treatment frequency of classic acupunc-
ture can be reduced to twice per week. As a result, both
the final outcome and patient compliance are improved.
For a high-quality RCT, use of the appropriate control
is crucial. In this trial, two questions must be addressed.
First, is the OAT treatment effective on CS neck pain?
Second, does the OAT treatment have a superior effect
to the control treatments in treating CS neck pain? The
sham and shallow acupuncture groups were designed as
control groups in this study to answer these questions.
Sham acupuncture is considered to be a placebo treat-
ment in acupuncture studies. In general, sham acupunc-
ture can be divided into two categories: non-penetrating
and penetrating sham acupuncture, which is determined
by whether the needle penetrates the skin during the
intervention. According to the literature, there are four
types of non-penetrating sham acupuncture in use: 1)
skin touch on standard points or non-points [24,25], 2)
blunt telescoping sham needle [26,27], 3) transcutaneous
electrical stimulation [28], and 4) sham laser acupunc-
ture [29,30]. It is reported the non-penetrating sham
acupuncture has been applied as a placebo in numerous
trials; however, it was also found that 40% of the subjects
in these trials could distinguish the sham acupuncture
from the real treatment [31], breaking the blind conceal-
ment. Therefore, we considered that non-penetrating
sham acupuncture would not be a useful placebo for this
trial. However, two types of penetrating sham acupunc-
ture are also available: 1) non-point deep puncturing
needle insertion [32,33] and 2) non-point superficial
needle insertion [34,35]. Although skin penetration is
believed to cause some therapeutic effect such as dimin-
ished pain intensity, it is considered non-specific, and
can be caused by other interventions. The greater the in-
sertion depth and the more stimulation induced by the
needle, the greater the effect. Consequently, we chose to
usethe non-point superficial needle-insertion method for
the trial. The needles are inserted into the sham points
to a depth of 3 mm and are retained at the subcutaneous
level. Because the needles are inserted on the patient’s
back, the patients can sense the needle penetration but
cannot distinguish the sham acupuncture from the real
one. Therefore, we believe that this method can serve as
an effective placebo intervention.
Considering the trial results, both pain intensity and
physical function are subjective feelings, therefore, we will
use the PRO and the validated scales and questionnaires
to assess the clinical outcome. For the evaluation of CS
neck pain, three aspects were included in the complete as-
sessment: neck pain, physical function, and QOL. The
NPQ will be used as the primary outcome to evaluate CS-
related neck pain, radiculopathy. and impairment of dailyfunctions, while for the secondary outcomes, the MPQ
will measure the pain intensity in general settings, and the
SF-36 will measure patient QOL changes caused by
changes in physical and mental conditions.
Salter et al. [12] proposed a protocol for an RCT to
evaluate the effect of acupuncture for neck pain, recom-
mending 229 cases for each arm based on the assump-
tion of 90% power to detect a five-point NPQ difference,
a 5% significance level, and a 14% drop-out rate during
follow-up. In our study, a total of 945 cases are required
from 9 centres, therefore, there will be 315 cases for
each arm, and at least 268 cases are required to
complete the trial and follow-up. The report of the study
results will follow the CONSORT 2010 guidelines [13],
and the operation details for acupuncture will be
reported in accordance with the 2010 CONSORT-
STRICTA extension [14] guidelines. Thus, this study will
be able to provide high-quality evidence for the efficacy
of the OAT for CS neck pain.
In conclusion, the multi-centre RCT design of this
trial will be able to assess and differentiate the effects of
the OAT.
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